Monoclonal antibody M195-Y-90

Drug Profile

Monoclonal antibody M195-Y-90

Alternative Names: Anti-CD33 Yttrium-90-labelled monoclonal antibody; Yttrium-90-labelled human M195 monoclonal antibody

Latest Information Update: 05 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Immunotherapies; Monoclonal antibodies; Radiopharmaceuticals
  • Mechanism of Action CD33 antigen inhibitors; Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Acute myeloid leukaemia; Cancer

Most Recent Events

  • 25 Jul 2000 Phase-I clinical trials for Acute myeloid leukaemia in USA (IV-infusion)
  • 25 Jul 2000 A phase I study in AML has been added to the therapeutic trials and adverse events sections
  • 12 May 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top